3E0H3TZ ICD-10-PCS Code: Introduction of Destructive Agent into Lower GI, Percutaneous Approach
Introduction of Destructive Agent into Low GI, Perc Approach
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | Section3 | Administration |
| 2 | Body SystemE | Physiological Systems and Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body System / RegionH | Lower GI |
| 5 | Approach3 | Percutaneous |
| 6 | SubstanceT | Destructive Agent |
| 7 | QualifierZ | No Qualifier |
Related Codes
Same operation — other Body System / Region
Same table and root operation, differing only in the body system / region character.
3E0D3TZ — Introduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach, 3E0E3TZ — Introduction of Destructive Agent into Products of Conception, Percutaneous Approach, 3E0F3TZ — Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach, 3E0G3TZ — Introduction of Destructive Agent into Upper GI, Percutaneous Approach, 3E0J3TZ — Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach, 3E0K3TZ — Introduction of Destructive Agent into Genitourinary Tract, Percutaneous Approach, 3E0L3TZ — Introduction of Destructive Agent into Pleural Cavity, Percutaneous Approach, 3E0M3TZ — Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach, +20 more
Same operation — other Approach
Same table and root operation, differing only in the approach character.
3E0H7TZ — Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening, 3E0H8TZ — Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic
Same operation — other Substance
Same table and root operation, differing only in the substance character.
3E0H33Z — Introduction of Anti-inflammatory into Lower GI, Percutaneous Approach, 3E0H36Z — Introduction of Nutritional Substance into Lower GI, Percutaneous Approach, 3E0H37Z — Introduction of Electrolytic and Water Balance Substance into Lower GI, Percutaneous Approach, 3E0H3BZ — Introduction of Anesthetic Agent into Lower GI, Percutaneous Approach, 3E0H3HZ — Introduction of Radioactive Substance into Lower GI, Percutaneous Approach, 3E0H3KZ — Introduction of Other Diagnostic Substance into Lower GI, Percutaneous Approach, 3E0H3NZ — Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Percutaneous Approach
Same procedure category (CCSR), other tables
AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of therapeutic substances, NEC (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.
XW00X27 — Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7, XW0136A — Introduction of Dasiglucagon into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 10, XW01397 — Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7, XW013TB — Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11, XW013W5 — Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5, XW01X27 — Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7, XW0333A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW03372 — Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2, XW03377 — Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033F3 — Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 3, XW033FA — Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033FB — Introduction of Valoctocogene Roxaparvovec-rvox into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW033MA — Introduction of Emapalumab-lzsg Anti-IFNy Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033Q9 — Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW033QB — Introduction of Iloprost into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW033R9 — Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW033W5 — Introduction of Caplacizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5, XW0433A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10, XW04372 — Introduction of Inactivated Coagulation Factor Xa into Central Vein, Percutaneous Approach, New Technology Group 2, XW04377 — Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7, +38 more
Contextual Map
Every relationship of 3E0H3TZ in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
PCS table
- 3E0[PCS table]— CMS ICD-10-PCS tables
- Administration — Section: Administration[Section]: “Administration”— CMS ICD-10-PCS tables
- Physiological Systems and Anatomical Regions — Body System: Physiological Systems and Anatomical Regions[Body System]: “Physiological Systems and Anatomical Regions”— CMS ICD-10-PCS tables
- Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables
Clinical classification (CCSR)
- ADM021 — Administration of therapeutic substances, NEC[CCSR category]: “Administration of therapeutic substances, NEC — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1
Nearest codes
- 3E013TZ — Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E023TZ — Introduction of Destructive Agent into Muscle, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E033TZ — Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E043TZ — Introduction of Destructive Agent into Central Vein, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E053TZ — Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E063TZ — Introduction of Destructive Agent into Central Artery, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E093TZ — Introduction of Destructive Agent into Nose, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
- 3E0B3TZ — Introduction of Destructive Agent into Ear, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
Change history
No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.
Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels